Cargando…
Protein Formulations Containing Polysorbates: Are Metal Chelators Needed at All?
Proteins are prone to post-translational modifications at specific sites, which can affect their physicochemical properties, and consequently also their safety and efficacy. Sources of post-translational modifications include oxygen and reactive oxygen species. Additionally, catalytic amounts of Fe(...
Autores principales: | Brovč, Ema Valentina, Pajk, Stane, Šink, Roman, Mravljak, Janez |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7278585/ https://www.ncbi.nlm.nih.gov/pubmed/32443662 http://dx.doi.org/10.3390/antiox9050441 |
Ejemplares similares
-
Pediatric Safety of Polysorbates in Drug Formulations
por: Kriegel, Christina, et al.
Publicado: (2019) -
Fluorescent Molecular Rotors as Dyes to Characterize Polysorbate-Containing IgG Formulations
por: Hawe, Andrea, et al.
Publicado: (2009) -
Effect of Fatty Acid Composition in Polysorbate 80 on the Stability of Therapeutic Protein Formulations
por: Pegues, Melissa A., et al.
Publicado: (2021) -
The effect of polysorbate 20 and polysorbate 80 on the solubility of quercetin
por: Erawati, Tristiana, et al.
Publicado: (2023) -
The measurement and control of high-risk host cell proteins for polysorbate degradation in biologics formulation
por: Li, Xuanwen, et al.
Publicado: (2022)